| Product Code: ETC12192367 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Israel continued to rely on imports of follicle-stimulating hormone, with top exporters being Switzerland, USA, Germany, China, and Belgium. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market. Despite a negative compound annual growth rate (CAGR) from 2020-24, there was a promising growth rate of 8.63% in 2024 compared to the previous year. This suggests potential for market expansion and diversification in the coming years, as Israel maintains its position as a key importer in the global follicle-stimulating hormone market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Follicle-Stimulating Hormone Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Follicle-Stimulating Hormone Market Revenues & Volume, 2022 & 2032F |
3.3 Israel Follicle-Stimulating Hormone Market - Industry Life Cycle |
3.4 Israel Follicle-Stimulating Hormone Market - Porter's Five Forces |
3.5 Israel Follicle-Stimulating Hormone Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Israel Follicle-Stimulating Hormone Market Revenues & Volume Share, By Form, 2022 & 2032F |
3.7 Israel Follicle-Stimulating Hormone Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Israel Follicle-Stimulating Hormone Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.9 Israel Follicle-Stimulating Hormone Market Revenues & Volume Share, By Dosage, 2022 & 2032F |
4 Israel Follicle-Stimulating Hormone Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infertility issues in Israel |
4.2.2 Growing awareness about fertility treatments |
4.2.3 Advancements in reproductive technologies and treatments |
4.3 Market Restraints |
4.3.1 High cost associated with follicle-stimulating hormone treatment |
4.3.2 Limited insurance coverage for fertility treatments in Israel |
4.3.3 Stringent regulations and approvals for fertility drugs |
5 Israel Follicle-Stimulating Hormone Market Trends |
6 Israel Follicle-Stimulating Hormone Market, By Types |
6.1 Israel Follicle-Stimulating Hormone Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By Recombinant FSH, 2022 - 2032F |
6.1.4 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By Urinary-Derived FSH, 2022 - 2032F |
6.1.5 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By Human FSH, 2022 - 2032F |
6.1.6 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By Synthetic FSH, 2022 - 2032F |
6.2 Israel Follicle-Stimulating Hormone Market, By Form |
6.2.1 Overview and Analysis |
6.2.2 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By Injection, 2022 - 2032F |
6.2.3 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By Powder, 2022 - 2032F |
6.2.4 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By Liquid, 2022 - 2032F |
6.2.5 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By Tablet, 2022 - 2032F |
6.3 Israel Follicle-Stimulating Hormone Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By Fertility Treatment, 2022 - 2032F |
6.3.3 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By IVF Procedures, 2022 - 2032F |
6.3.4 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By Ovulation Induction, 2022 - 2032F |
6.3.5 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By Hormone Replacement Therapy, 2022 - 2032F |
6.4 Israel Follicle-Stimulating Hormone Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By Fertility Clinics, 2022 - 2032F |
6.4.4 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By Gynecology Centers, 2022 - 2032F |
6.4.5 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By Pharmaceutical Companies, 2022 - 2032F |
6.5 Israel Follicle-Stimulating Hormone Market, By Dosage |
6.5.1 Overview and Analysis |
6.5.2 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By 75 IU-150 IU, 2022 - 2032F |
6.5.3 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By 225 IU-450 IU, 2022 - 2032F |
6.5.4 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By 50 IU-100 IU, 2022 - 2032F |
6.5.5 Israel Follicle-Stimulating Hormone Market Revenues & Volume, By 10 mg-50 mg, 2022 - 2032F |
7 Israel Follicle-Stimulating Hormone Market Import-Export Trade Statistics |
7.1 Israel Follicle-Stimulating Hormone Market Export to Major Countries |
7.2 Israel Follicle-Stimulating Hormone Market Imports from Major Countries |
8 Israel Follicle-Stimulating Hormone Market Key Performance Indicators |
8.1 Number of fertility clinics offering follicle-stimulating hormone treatment |
8.2 Adoption rate of assisted reproductive technologies in Israel |
8.3 Success rates of in vitro fertilization procedures using follicle-stimulating hormone |
9 Israel Follicle-Stimulating Hormone Market - Opportunity Assessment |
9.1 Israel Follicle-Stimulating Hormone Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Israel Follicle-Stimulating Hormone Market Opportunity Assessment, By Form, 2022 & 2032F |
9.3 Israel Follicle-Stimulating Hormone Market Opportunity Assessment, By Application, 2022 & 2032F |
9.4 Israel Follicle-Stimulating Hormone Market Opportunity Assessment, By End User, 2022 & 2032F |
9.5 Israel Follicle-Stimulating Hormone Market Opportunity Assessment, By Dosage, 2022 & 2032F |
10 Israel Follicle-Stimulating Hormone Market - Competitive Landscape |
10.1 Israel Follicle-Stimulating Hormone Market Revenue Share, By Companies, 2025 |
10.2 Israel Follicle-Stimulating Hormone Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here